Agree.
I am a little confused - this is not the CRE data is it? Vaccines is another stream right - So there is another angle yet to come?
A deal is key for big valuation change but I think I am confused by what is due out and what was annouced. My sell orders are all in for the trade (no harm in 20-40% in less than 6 months) but if CRE is sill to come then maybe I rethink back to the higher levels I first thought were on offer.
Ann: Successful In-vivo Results Peptide Vaccine T-Cell Expansion, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.005(0.39%) |
Mkt cap ! $746.5M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.28 | $4.538M | 3.587M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25835 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58914 | 2 |
View Market Depth
| Last trade - 11.26am 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |